Alkyl Amines Chemicals Limited (AACL) has initiated a postal ballot process to seek shareholder approval for a revision in the remuneration of its Whole-time Director-Operations, Mr. Rakesh S. Goyal. The key proposal is to increase his commission from 0.10% to 0.30% of net profits, effective January 1, 2026.

Proposed Remuneration Changes

The company plans to modify Mr. Goyal's compensation structure as follows:

Other components of Mr. Goyal's remuneration package, which were effective from April 1, 2025, will remain unchanged. These include:

• Basic Salary: Rs. 6,00,000 to Rs. 7,20,000 per month with annual increments of Rs. 60,000 per month
• House Rent Allowance: 40% of basic salary
• Other benefits: Leave Travel Assistance, Mediclaim Policy Premium, Provident Fund, Gratuity, and additional perks as per company policy

Voting Process

AACL has outlined the following schedule for the postal ballot:

• E-voting Period: November 21, 2025 to December 20, 2025
• Result Declaration: By December 23, 2025

The company has engaged National Securities Depository Limited (NSDL) to provide the e-voting facility to its shareholders.

Rationale and Approval Process

The proposed revision aims to align Mr. Goyal's compensation with industry standards, considering his 30 years of experience in manufacturing, technology transfer, process development, quality management, and sales and marketing. The Nomination and Remuneration Committee approved this change on October 23, 2025, followed by the Board of Directors' approval on November 4, 2025.

Mr. Goyal, who holds 12,295 equity shares (0.02% of the company's paid-up equity share capital), is not related to any other Director on the Board. He has attended all Board meetings in the current financial year and serves as a member of the Risk Management Committee.

Shareholders are encouraged to participate in the e-voting process to voice their decision on this proposed remuneration change for a key executive of Alkyl Amines Chemicals Limited.

Alkyl Amines Chemicals Limited , a leading manufacturer of aliphatic amines and amine derivatives, reported a subdued performance for the first half of fiscal year 2026, primarily due to geopolitical pressures and market challenges. The company's Executive Director, Kirat Patel, provided insights into the factors affecting their performance during a recent earnings conference call.

Key Highlights

• Flat topline performance despite marginal volume growth
• US government actions significantly impacted the company's operations
• Methylamines segment more affected than ethylamines
• Anti-dumping duties on acetonitrile expected to show benefits from Q4 onwards

Impact of US Government Actions

Alkyl Amines faced challenges on multiple fronts due to US government actions:

1. Direct US exports affected
2. Reduced customer demand due to their US export challenges
3. Increased Chinese competition in domestic markets
4. Sanctions on some Indian distributors in their supply chain

Segment Performance

The methylamines segment experienced a more significant impact compared to ethylamines. The overall market is facing a capacity overhang with the entry of Aarti Drugs as the fourth player in the industry.

Capacity Utilization and Future Projects

Mr. Patel mentioned that the company's ethylamine plant, commissioned about a year and a half ago with a capacity of 30,000 tons, is currently operating at 60-70% utilization. This provides room for growth as market conditions improve.

Alkyl Amines is also progressing on a new Rs. 120.00 crore project in Kurkumbh, targeting the dyes, pigments, and electronics markets. The mechanical completion of this project is expected by February-March 2026.

Acetonitrile Market

The implementation of anti-dumping duties on acetonitrile in June is anticipated to yield benefits from the fourth quarter onwards. However, Chinese competitors remain aggressive on pricing, presenting ongoing challenges in this segment.

Market Outlook

Management anticipates that the current subdued demand conditions may continue due to ongoing geopolitical uncertainties. However, they remain optimistic about long-term growth prospects as global trade situations stabilize.

Financial Performance

While specific financial figures were not disclosed, the company reported:

• Flat topline performance in H1 FY26
• Marginal volume growth
• Managed to retain profitability despite market pressures

Conclusion

Alkyl Amines Chemicals Limited faces a challenging business environment due to geopolitical pressures and market dynamics. However, the company's diversified product portfolio, ongoing expansion projects, and potential benefits from anti-dumping duties on acetonitrile provide some optimism for future growth. As global trade situations stabilize, the company expects to return to its normal growth trajectory.